Can genomics bend the cost curve?

JAMA. 2012 Mar 14;307(10):1031-2. doi: 10.1001/jama.2012.261.
No abstract available

MeSH terms

  • Biomedical Technology / economics
  • Biomedical Technology / trends
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / genetics
  • Breast Neoplasms / therapy
  • Cost Control
  • Cost-Benefit Analysis
  • Delivery of Health Care / economics
  • Delivery of Health Care / standards
  • Delivery of Health Care / trends
  • Female
  • Gene Expression Profiling / economics
  • Genetic Testing / economics
  • Genomics / economics*
  • Genomics / trends*
  • Health Care Costs / trends*
  • Health Expenditures / trends*
  • Humans
  • Patient Care Planning
  • United States